Predictors of irreversible renal dysfunction in patients with idiopathic retroperitoneal fibrosis.

Rheumatology (Oxford)

Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.

Published: October 2024

AI Article Synopsis

  • The study focuses on idiopathic retroperitoneal fibrosis (iRPF) and its potential to cause permanent kidney damage, aiming to identify predictors of irreversible renal dysfunction in affected patients.
  • It involved 83 patients from a hospital, with data collected through follow-ups and analyses using various statistical methods to determine risk factors.
  • The researchers developed a prognostic score based on specific health indicators that effectively predicted irreversible renal dysfunction with high sensitivity and specificity across training and validation patient groups.

Article Abstract

Objectives: Idiopathic retroperitoneal fibrosis (iRPF) can lead to irreversible kidney damage. This study aimed to investigate predictors of irreversible renal dysfunction in patients with iRPF.

Methods: Eighty-three patients with newly diagnosed iRPF were enrolled between January 2010 and Sep 2022 at Zhongshan Hospital of Fudan University, including 60 in the training set and 23 in the validation set. They were regularly contacted or followed up via outpatient examinations by specialist doctors, who documented their condition and treatment progress. Predictors of irreversible renal dysfunction were identified using univariate and multivariate regression, logistic model, and receiver operating curve analyses.

Results: In the training set, over a median follow-up of 29 months, 16.7% of patients had an estimated glomerular filtration rate (eGFR) of < 60 ml/min/1.73m2 at the last follow-up, and 25% had hydronephrosis or required prolonged double-J stents. A prognostic score was developed by assigning 1, 1, and 2 points for peripheral CD19+ B cells <9.3%, serum creatinine (sCr) ≥120 μmol/l, and no response at 6 months, respectively. A score of ≥ 2 for predicting irreversible renal dysfunction had sensitivity and specificity of 100% and 92%, respectively. In the validation set, 21.7% of patients suffered from irreversible renal dysfunction. The sensitivity and specificity for predicting irreversible renal dysfunction were 100% and 94.4%, respectively.

Conclusions: A prognostic score based on factors including CD19+ B cells <9.3% and sCr ≥120 μmol/l at baseline, and no response at 6 months, is suitable for predicting irreversible renal dysfunction in iRPF.

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keae565DOI Listing

Publication Analysis

Top Keywords

predictors irreversible
12
irreversible renal
12
renal dysfunction
12
dysfunction patients
8
idiopathic retroperitoneal
8
retroperitoneal fibrosis
8
training set
8
patients
4
patients idiopathic
4
fibrosis objectives
4

Similar Publications

Background: Chronic kidney disease (CKD) causes progressive and irreversible damage to the kidneys. Renal biopsies are essential for diagnosing the etiology and prognosis of CKD, while accurate quantification of tubulo-interstitial injuries from whole slide images (WSIs) of renal biopsy specimens is challenging with visual inspection alone.

Methods: We develop a deep learning-based method named DLRS to quantify interstitial fibrosis and inflammatory cell infiltration as tubulo-interstitial injury scores, from WSIs of renal biopsy specimens.

View Article and Find Full Text PDF

Background: Geographic atrophy (GA) is a form of advanced age-related macular degeneration (AMD) that can cause irreversible vision impairment and is responsible for approximately 20% of legal blindness in the United States. There is limited real-world evidence assessing health outcomes and health care resource use (HCRU) among individuals with GA.

Objective: To examine the progression from GA without subfoveal involvement (SFI) to GA with SFI, progression to irreversible blindness, and HCRU among older individuals with GA enrolled in Medicare Advantage Prescription Drug (MAPD) plans.

View Article and Find Full Text PDF

Anti-IgLON5 disease was identified 10 years ago, thanks to the discovery of IgLON5 antibodies and the joint effort of specialists in sleep medicine, neuroimmunology, and neuropathology. Without this collaboration, it would have been impossible to untangle fundamental aspects of this disease. After the seminal description in 2014, today there is growing evidence that most patients present a chronic progressive course with gait instability, abnormal movements, bulbar dysfunction, and a sleep disorder characterized by nonrapid eye movement and REM parasomnias, and obstructive sleep apnea with stridor.

View Article and Find Full Text PDF

Swept-source optical coherence tomography assessment of Schlemm's canal after phacoemulsification with goniosynechialysis in Chinese patients with primary angle-closure glaucoma.

Quant Imaging Med Surg

December 2024

Department of Ophthalmology & Visual Science, Eye, Ear, Nose, and Throat Hospital, Shanghai Medical College, Fudan University, Shanghai, China.

Background: Primary angle-closure glaucoma (PACG) is a leading cause of irreversible blindness worldwide. However, the features of the morphology of Schlemm's canal (SC) in PACG eyes after phacoemulsification with goniosynechialysis (phaco-GSL) surgery are still unknown. This study aimed to evaluate changes in the SC in Chinese patients with PACG after phaco-GSL using swept-source optical coherence tomography (SS-OCT).

View Article and Find Full Text PDF

Background/objectives: Neovascular age-related macular degeneration (nAMD) is a retinal disorder leading to irreversible central vision loss. The pro-re-nata (PRN) treatment for nAMD involves frequent intravitreal injections of anti-VEGF medications, placing a burden on patients and healthcare systems. Predicting injections needs at each monitoring session could optimize treatment outcomes and reduce unnecessary interventions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!